Literature DB >> 11375399

Activating transcription factor 3 induces DNA synthesis and expression of cyclin D1 in hepatocytes.

A L Allan1, C Albanese, R G Pestell, J LaMarre.   

Abstract

Activating transcription factor 3 (ATF3) is an early response gene that is induced rapidly during in vivo situations of cellular growth such as liver regeneration. However, neither the physiological function nor the potential target genes of this transcription factor related to cellular proliferation have been identified in the liver or other tissues. We demonstrate here that endogenous ATF3 mRNA expression is rapidly induced up to 4-fold upon mitogenic stimulation of quiescent Hepa 1-6 mouse hepatoma cells. Overexpression of exogenous ATF3 results in a significant, dose-dependent increase in DNA synthesis of up to 140% over control cells. ATF3-transfected cells also display significantly higher rates of [(3)H]thymidine incorporation in comparison with nontransfected controls in the presence of serum. Northern blot analysis and co-transfection experiments demonstrate that overexpression of ATF3 enhances cyclin D1 mRNA expression and activates the cyclin D1 promoter 2.5-fold when activating protein-1 (AP-1) and cyclic AMP response element (CRE) sites within the promoter are intact. ATF3-mediated promoter activation is reduced to 1.3-fold and 1.6-fold respectively when the AP-1 or CRE sites are mutated, and mutation of both sites simultaneously leads to the complete abrogation of promoter activation. Furthermore, DNA-binding studies demonstrate that ATF3 binds directly to the AP-1 site within the cyclin D1 promoter. These results indicate that ATF3 expression stimulates hepatocellular proliferation, suggesting that this effect is mediated, at least in part, by the ATF3-dependent activation of cyclin D1 transcription.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11375399     DOI: 10.1074/jbc.M103196200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  3,3'-diindolylmethane induces activating transcription factor 3 (ATF3) via ATF4 in human colorectal cancer cells.

Authors:  Seong-Ho Lee; Kyung-Won Min; Xiaobo Zhang; Seung Joon Baek
Journal:  J Nutr Biochem       Date:  2012-07-21       Impact factor: 6.048

2.  Stress response gene ATF3 is a target of c-myc in serum-induced cell proliferation.

Authors:  Kiyoshi Tamura; Bayin Hua; Susumu Adachi; Isil Guney; Junya Kawauchi; Masaki Morioka; Mimi Tamamori-Adachi; Yujiro Tanaka; Yusaku Nakabeppu; Makoto Sunamori; John M Sedivy; Shigetaka Kitajima
Journal:  EMBO J       Date:  2005-06-30       Impact factor: 11.598

3.  Regulation of gene expression by tobacco product preparations in cultured human dermal fibroblasts.

Authors:  Gloria E Malpass; Subhashini Arimilli; G L Prasad; Allyn C Howlett
Journal:  Toxicol Appl Pharmacol       Date:  2014-06-10       Impact factor: 4.219

4.  Interaction between Drosophila bZIP proteins Atf3 and Jun prevents replacement of epithelial cells during metamorphosis.

Authors:  Petra Sekyrova; Dirk Bohmann; Marek Jindra; Mirka Uhlirova
Journal:  Development       Date:  2010-01       Impact factor: 6.868

5.  A key role for ATF3 in regulating mast cell survival and mediator release.

Authors:  Mark Gilchrist; William R Henderson; Andrew Morotti; Carrie D Johnson; Alex Nachman; Frank Schmitz; Kelly D Smith; Alan Aderem
Journal:  Blood       Date:  2010-03-04       Impact factor: 22.113

6.  Cisplatin induces cytotoxicity through the mitogen-activated protein kinase pathways and activating transcription factor 3.

Authors:  Carly St Germain; Nima Niknejad; Laurie Ma; Kyla Garbuio; Tsonwin Hai; Jim Dimitroulakos
Journal:  Neoplasia       Date:  2010-07       Impact factor: 5.715

7.  Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3.

Authors:  Su-Hyeong Kim; Arumugam Nagalingam; Neeraj K Saxena; Shivendra V Singh; Dipali Sharma
Journal:  Carcinogenesis       Date:  2010-12-16       Impact factor: 4.944

8.  Activating transcription factor 3 interferes with p21 activation in histone deacetylase inhibitor-induced growth inhibition of epidermoid carcinoma cells.

Authors:  Zhen-Feng Hao; You-Ming Su; Cong-min Wang; Rong-Ya Yang
Journal:  Tumour Biol       Date:  2014-11-05

9.  Oxidative stress-responsive transcription factor ATF3 potentially mediates diabetic angiopathy.

Authors:  Aki Okamoto; Yasuhiko Iwamoto; Yoshiro Maru
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

10.  Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combination.

Authors:  Carly St Germain; Anna O'Brien; Jim Dimitroulakos
Journal:  Cancer Cell Int       Date:  2010-09-09       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.